Patent vs Subpatent Infections: What Do They Mean in Experimental Malaria Studies?
If you’ve ever worked with Plasmodium parasites—whether in the lab or the field—you’ve likely come across the terms patent and subpatent infections. But what do they really mean, and why do they matter in experimental infections?
Let’s look at the details.
What Is a Patent Infection?
A patent infection simply means the parasite is detectable using standard diagnostic tools. These include:
Light microscopy (blood smears)
Rapid diagnostic tests (RDTs)
Standard PCR methods
In malaria research, when an infection is called patent, it means the number of parasites (parasitemia) has risen above a threshold where they can be seen or detected easily. For microscopy, this usually means more than 50–100 parasites per microliter of blood.
So, a patent infection is:
- Visible
- Detectable with routine methods
- Often associated with clinical symptoms
What About Subpatent Infections?
Now here’s where it gets interesting.
A subpatent infection is one where the parasite is present but flying under the radar—too few in number to be picked up by the usual tests. However, with sensitive molecular techniques like:
qPCR (quantitative PCR)
RT-qPCR (reverse transcription PCR)
Digital droplet PCR (ddPCR)
...we can still detect these low-level infections.
Subpatent infections are:
- Undetectable by routine tests
- Detectable only with advanced molecular tools
- Often silent but potentially transmissible
They are common in:
Early stages of infection
People with partial immunity
Populations in low-transmission areas
Why It Matters in Experimental Infections
In experimental malaria research—whether you’re studying blood-stage parasites in vitro, mosquito infection, or host responses—this distinction is crucial.
If you're monitoring infection progression in an animal model or after challenge, you’ll need to know when the infection becomes patent.
To capture early infection events or low-level persistence, molecular tools are key to identifying subpatent infections.
Some interventions (e.g., vaccines or antimalarials) might suppress parasites below the patent threshold without clearing them completely. Subpatent detection helps uncover these effects.
Conclusion
Understanding patent vs subpatent infections helps you:
Choose the right detection method
Accurately interpret infection dynamics
Design better interventions and surveillance strategies
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments